Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Fayetteville, GA
NPI: 1457545709Primary Practice Location
PIEDMONT FAYETTE HOSPITAL
1255 Highway 54 W, Fayetteville, GA
Primary Employer
Piedmont Cancer Institute - Newnan
piedmontcancerinstitute.com
HQ Phone
Get M.D. Trevor's Phone Numberphone_androidMobile
Get M.D. Trevor's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardGA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 641 | 1,509 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 466 | 725 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 189 | 372 |
| 4 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 141 | 512 |
| 5 | 96413Infusion of chemotherapy into a vein up to 1 hour | 133 | 632 |
Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials.
Authors: Sujith Kalmadi, Rajesh Malik, Philip Lammers, Renata Ferrarotto
Publication Date: 2021-03-01
Authors: Lyudmila Bazhenova, Ira Oliff, Goetz Kloecker
Journal: Lancet Respir Med
Publication Date: 2024-09-09
Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies.
Authors: Leonard Appleman, Athanassios Argiris, Ronald Stoller
Publication Date: 2011-05-27
Lead Sponsor: BeyondSpring Pharmaceuticals Inc.
Intervention / Treatment: DRUG: Docetaxel + Plinabulin (DP), DRUG: Docetaxel (D)
Lead Sponsor: Syros Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Azacitidine, DRUG: Tamibarotene
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: Placebo, DRUG: Telaglenastat, DRUG: Carboplatin Chemotherapy, DRUG: Pemetrexed Chemotherapy, BIOLOGICAL: Pembrolizumab Immunotherapy, DIETARY_SUPPLEMENT: Folic acid 400 -1000 μg, DIETARY_SUPPLEMENT: Vitamin B12 1000 μg, DRUG: Dexamethasone 4 mg
